Pulse nav.journalClub النقاشات النشطة الرائج استكشاف الباحثون

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

الرئيسية استكشاف nav.journalClub الرائج

⌘+K

© Synapse Social LLC, 2026

سياسة الخصوصية

Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group | Synapse

May 28, 2008Open Access

Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group

Key Points

Key points are not available for this paper at this time.

Abstract

Postoperative cisplatin-based chemotherapy significantly improves survival in patients with NSCLC.

اسأل الذكاء الاصطناعي

Like

Bookmark

Share

View Full Paper

اسأل الذكاء الاصطناعي

Like

Bookmark

Share

View Full Paper

Cite This Study

Pignon et al. (Wed,) studied this question.

synapsesocial.com/papers/69d7c6f005ee2ba81dbede0f https://doi.org/https://doi.org/10.1200/jco.2007.13.9030

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials1995 · 2,859 citations
2Adjuvant Therapy for Early Lung Cancer: Reflections and Perspectives2006 · 6 citations
3Vascular toxicity associated with antineoplastic agents.1986 · 253 citations
4Surgery and adjuvant chemotherapy (CT) compared to surgery alone in non-small cell lung cancer (NSCLC): A meta-analysis using individual patient data (IPD) from randomized clinical trials (RCT)2007 · 40 citations
5Adjuvant chemotherapy in stage IB nonsmall cell lung cancer2009 · 11 citations